ABBV AbbVie
- 155.340
- -1.720-1.10%
- 155.500
- +0.160+0.10%
AbbVie News
Express News | NYSE Order Imbalance 89860.0 Shares on Buy Side
Abbvie Showcases Strong Solid Tumor Product Line at Asco 2024 with New Data from Its Innovative Antibody Drug Conjugate (ADC) Platform
Abbvie Showcases Strong Solid Tumor Product Line at Asco 2024 with New Data from Its Innovative Antibody Drug Conjugate (ADC) Platform
Express News | Abbvie Inc -New Safety and Efficacy Data in Heavily Pre-Treated Patients With Metastatic Colorectal Cancer (Crc), From a Phase 1 Study of Abbv-400
Express News | Abbvie Showcases Robust Solid Tumor Pipeline at Asco 2024 With New Data From Its Innovative Antibody-Drug Conjugate (ADC) Platform
Abbvie Stock: Is Wall Street Bullish or Bearish?
The wave of US biopharmaceutical mergers and acquisitions has set off who will be the next potential target?
The Zhitong Finance App learned that Wells Fargo released its annual list of potential mergers and acquisitions in the biopharmaceutical industry, adding diet drug developers Viking Therapeutics (VKTX.US), gene editing company CRISPR Therapeutics (CRSP.US), and Intellia Therapeutics (NTLA.US) to the list of potential acquisition targets in 2024. The investment bank has identified 31 such companies in the biopharmaceutical small to medium cap sector, and these companies are highly or moderately suitable for the following large pharmaceutical companies
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
Deutsche Numis Maintains AbbVie(ABBV.US) With Hold Rating, Raises Target Price to $175
Deutsche Numis analyst James Shin maintains $AbbVie(ABBV.US)$ with a hold rating, and adjusts the target price from $170 to $175.According to TipRanks data, the analyst has a success rate of 61.5% and
News On Landos Biopharma Inc. (LABP) Now Under ABBV
News On Landos Biopharma Inc. (LABP) Now Under ABBV
Express News | NYSE Order Imbalance 226318.0 Shares on Buy Side
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
U.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected individuals about their personal and highly sensitive medical information stolen during a cyberattack ear
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
PALM BEACH, Fla., May 24, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention, diagnosis,
Express News | AbbVie: Upadacitinib included in CDE's list of breakthrough therapeutic varieties
Express News | Abbvie Completes Acquisition of Landos Biopharma
Express News | NYSE Order Imbalance 178533.0 Shares on Buy Side
8 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Why AbbVie (ABBV) Is a Top Value Stock for the Long-Term
AbbVie Completes Acquisition of Landos Biopharma
- Adds first-in-class investigational asset, NX-13, to AbbVie's pipeline with the potential to offer a novel approach to the treatment of ulcerative colitis (UC) and Crohn's disease (CD)NORTH CHICAG
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
Analysis
Price Target
No Data
